HAVLF   $0.0344  -35.09% Market Open

HAVN Life Sciences Inc
Total Cash 13.99K
totalCashPerShare 0.001
EBITDA -3.50M
Total Debt 26.23K
quickRatio 0.598
currentRatio 2.677
Total Revenue 586.98K
debtToEquity 3.131
Revenue/Share 0.082
ROA -0.30267
ROE -2.3452
grossProfits
freeCashflow -708.92K
operatingCashflow -2.61M
earningsGrowth
revenueGrowth
grossMargins 0.3554
ebitdaMargins 0.0
operatingMargins 53.62728
profitMargins 0.0
enterpriseValue 13.72K
forwardPE
floatShares 14.22M
sharesOutstanding 14.74M
sharesShort
sharesShortPriorMonth
dateShortInterest
sharesPercentSharesOut
heldPercentInsiders 0.04%
heldPercentInstitutions 0.0
Short Ratio help_outline
shortPercentOfFloat
impliedSharesOutstanding
bookValue 0.057
Price To Book help_outline 0.00
earningsQuarterlyGrowth
netIncomeToCommon -15.71M
trailingEps -2.25%
forwardEps
enterpriseToEbitda -0.00
lastDividendValue
lastDividendDate
currentQuarterEstimate
institutionsCount 0
lastUpdated Nov. 7, 2024, 3:27 a.m.